25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Opko Health Inc
Buy, Hold or Sell?

Let's analyze Opko together

I guess you are interested in Opko Health Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Opko Health Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Opko Health Inc

I send you an email if I find something interesting about Opko Health Inc.

1. Quick Overview

1.1. Quick analysis of Opko (30 sec.)










1.2. What can you expect buying and holding a share of Opko? (30 sec.)

How much money do you get?

How much money do you get?
ILA0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
ILA2.00
Expected worth in 1 year
ILA2.02
How sure are you?
35.5%

+ What do you gain per year?

Total Gains per Share
ILA0.02
Return On Investment
0.0%

For what price can you sell your share?

Current Price per Share
ILA629.90
Expected price per share
ILA527.80 - ILA724.30
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Opko (5 min.)




Live pricePrice per Share (EOD)
ILA629.90
Intrinsic Value Per Share
ILA-500.95 - ILA-587.06
Total Value Per Share
ILA-498.95 - ILA-585.05

2.2. Growth of Opko (5 min.)




Is Opko growing?

Current yearPrevious yearGrowGrow %
How rich?$3.7m$4.2m-$533k-14.5%

How much money is Opko making?

Current yearPrevious yearGrowGrow %
Making money-$60.7m-$52.3m-$8.4m-13.9%
Net Profit Margin-34.2%-27.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Opko (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#24 / 136

Most Revenue
#37 / 136

Most Profit
#117 / 136
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Opko?

Welcome investor! Opko's management wants to use your money to grow the business. In return you get a share of Opko.

First you should know what it really means to hold a share of Opko. And how you can make/lose money.

Speculation

The Price per Share of Opko is ILA629.90. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Opko.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Opko, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ILA2.00. Based on the TTM, the Book Value Change Per Share is ILA0.00 per quarter. Based on the YOY, the Book Value Change Per Share is ILA-0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ILA0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Opko.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ILA% of Price per ShareILA% of Price per ShareILA% of Price per ShareILA% of Price per ShareILA% of Price per Share
Usd Eps-0.010.0%-0.080.0%-0.070.0%-0.050.0%-0.060.0%
Usd Book Value Change Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Price Per Share1.26-1.37-1.50-2.28-3.28-
Price to Earnings Ratio-21.29--7.92--9.32--2.14--16.12-
Price-to-Total Gains Ratio2,298.40-124,431.30--19,948.18-25,844.55--353,912.90-
Price to Book Ratio234.83-275.42-275.36-373.64-478.10-
Price-to-Total Gains Ratio2,298.40-124,431.30--19,948.18-25,844.55--353,912.90-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.6875021
Number of shares592
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (592 shares)0.01-0.04
Gains per Year (592 shares)0.03-0.16
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
100-100-0-10
200-100-0-10
300-100-0-10
400-100-1-10
500-100-1-10
600-100-1-10
700-100-1-10
800-100-1-10
900-100-1-10
1000-100-2-10

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%5.026.00.016.1%5.026.00.016.1%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%8.012.00.040.0%11.020.00.035.5%11.020.00.035.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.031.00.0%0.00.031.00.0%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%8.012.00.040.0%11.020.00.035.5%11.020.00.035.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Opko Health Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2050.004+5081%-0.060+129%-0.025+112%0.065+217%
Book Value Per Share--2.0021.866+7%2.031-1%2.224-10%2.409-17%
Current Ratio--1.6301.718-5%1.785-9%1.698-4%1.564+4%
Debt To Asset Ratio--0.2950.317-7%0.280+5%0.300-2%0.290+2%
Debt To Equity Ratio--0.4190.467-10%0.389+8%0.431-3%0.410+2%
Dividend Per Share----0%-0%-0%-0%
Eps---5.520-30.563+454%-25.436+361%-19.931+261%-23.473+325%
Free Cash Flow Per Share---18.026-11.361-37%-13.272-26%-6.326-65%-6.326-65%
Free Cash Flow To Equity Per Share---19.159-9.083-53%-10.997-43%-6.605-66%-6.605-66%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---587.056--------
Intrinsic Value_10Y_min---500.951--------
Intrinsic Value_1Y_max---40.751--------
Intrinsic Value_1Y_min---40.017--------
Intrinsic Value_3Y_max---136.217--------
Intrinsic Value_3Y_min---129.766--------
Intrinsic Value_5Y_max---248.292--------
Intrinsic Value_5Y_min---229.272--------
Market Cap429896046739.200+24%327655787357.700379168225122.450-14%432465568341.225-24%601885209198.230-46%853294672135.297-62%
Net Profit Margin---0.057-0.342+504%-0.272+382%-0.193+241%-0.214+278%
Operating Margin----0%-0.1890%-0.0690%-0.1200%
Operating Ratio--2.0552.115-3%1.886+9%1.823+13%1.773+16%
Pb Ratio314.649+25%234.825275.418-15%275.363-15%373.640-37%478.103-51%
Pe Ratio-28.527-34%-21.290-7.924-63%-9.324-56%-2.138-90%-16.122-24%
Price Per Share629.900+25%470.100512.700-8%559.625-16%852.810-45%1222.916-62%
Price To Free Cash Flow Ratio-8.736-34%-6.520-1.917-71%-19.663+202%-7.305+12%-4.713-28%
Price To Total Gains Ratio3079.688+25%2298.399124431.297-98%-19948.178+968%25844.550-91%-353912.896+15498%
Quick Ratio--0.4800.557-14%0.667-28%0.701-32%0.696-31%
Return On Assets---1.943-11.274+480%-8.918+359%-6.724+246%-7.221+272%
Return On Equity---2.757-16.712+506%-12.320+347%-9.583+248%-10.170+269%
Total Gains Per Share--0.2050.004+5081%-0.060+129%-0.025+112%0.065+217%
Usd Book Value--3738054.2433671510.562+2%4204573.964-11%4242485.564-12%4548902.334-18%
Usd Book Value Change Per Share--0.0010.000+5081%0.000+129%0.000+112%0.000+217%
Usd Book Value Per Share--0.0050.005+7%0.005-1%0.006-10%0.006-17%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.015-0.082+454%-0.068+361%-0.053+261%-0.063+325%
Usd Free Cash Flow---33659788.419-21522730.068-36%-27472856.847-18%-11298864.404-66%-7289589.938-78%
Usd Free Cash Flow Per Share---0.048-0.030-37%-0.036-26%-0.017-65%-0.017-65%
Usd Free Cash Flow To Equity Per Share---0.051-0.024-53%-0.029-43%-0.018-66%-0.018-66%
Usd Market Cap1151691509.214+24%877789854.3311015791675.103-14%1158575257.586-24%1612450475.442-46%2285976426.650-62%
Usd Price Per Share1.688+25%1.2591.374-8%1.499-16%2.285-45%3.276-62%
Usd Profit---10307384.989-60788315.592+490%-52319856.106+408%-39176614.938+280%-45155287.031+338%
Usd Revenue--182228165.128179134199.226+2%217090731.853-16%294410972.709-38%279707849.638-35%
Usd Total Gains Per Share--0.0010.000+5081%0.000+129%0.000+112%0.000+217%
 EOD+6 -2MRQTTM+21 -11YOY+14 -185Y+15 -1710Y+16 -16

3.3 Fundamental Score

Let's check the fundamental score of Opko Health Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-28.527
Price to Book Ratio (EOD)Between0-1314.649
Net Profit Margin (MRQ)Greater than0-0.057
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.480
Current Ratio (MRQ)Greater than11.630
Debt to Asset Ratio (MRQ)Less than10.295
Debt to Equity Ratio (MRQ)Less than10.419
Return on Equity (MRQ)Greater than0.15-2.757
Return on Assets (MRQ)Greater than0.05-1.943
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Opko Health Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.848
Ma 20Greater thanMa 50571.715
Ma 50Greater thanMa 100574.578
Ma 100Greater thanMa 200550.623
OpenGreater thanClose624.000
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Opko Health Inc

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 2007 and is headquartered in Miami, Florida.

Fundamental data was last updated by Penke on 2024-11-15 01:20:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Opko earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Opko to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -5.7% means that -0.06 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Opko Health Inc:

  • The MRQ is -5.7%. The company is making a loss. -1
  • The TTM is -34.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-5.7%TTM-34.2%+28.5%
TTM-34.2%YOY-27.2%-6.9%
TTM-34.2%5Y-19.3%-14.9%
5Y-19.3%10Y-21.4%+2.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.7%-2.5%-3.2%
TTM-34.2%-7.4%-26.8%
YOY-27.2%-0.9%-26.3%
5Y-19.3%-2.1%-17.2%
10Y-21.4%-0.1%-21.3%
4.3.1.2. Return on Assets

Shows how efficient Opko is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Opko to the Diagnostics & Research industry mean.
  • -194.3% Return on Assets means that Opko generated -1.94 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Opko Health Inc:

  • The MRQ is -194.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1,127.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-194.3%TTM-1,127.4%+933.1%
TTM-1,127.4%YOY-891.8%-235.6%
TTM-1,127.4%5Y-672.4%-454.9%
5Y-672.4%10Y-722.1%+49.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-194.3%-1.1%-193.2%
TTM-1,127.4%-1.3%-1,126.1%
YOY-891.8%-0.9%-890.9%
5Y-672.4%-0.2%-672.2%
10Y-722.1%-0.5%-721.6%
4.3.1.3. Return on Equity

Shows how efficient Opko is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Opko to the Diagnostics & Research industry mean.
  • -275.7% Return on Equity means Opko generated -2.76 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Opko Health Inc:

  • The MRQ is -275.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1,671.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-275.7%TTM-1,671.2%+1,395.4%
TTM-1,671.2%YOY-1,232.0%-439.2%
TTM-1,671.2%5Y-958.3%-712.8%
5Y-958.3%10Y-1,017.0%+58.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-275.7%-0.3%-275.4%
TTM-1,671.2%-0.7%-1,670.5%
YOY-1,232.0%0.2%-1,232.2%
5Y-958.3%-0.9%-957.4%
10Y-1,017.0%-0.9%-1,016.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Opko Health Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Opko is operating .

  • Measures how much profit Opko makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Opko to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated 0.00  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Opko Health Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-18.9%+18.9%
TTM-5Y-6.9%+6.9%
5Y-6.9%10Y-12.0%+5.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--11.5%+11.5%
TTM--13.2%+13.2%
YOY-18.9%3.4%-22.3%
5Y-6.9%3.1%-10.0%
10Y-12.0%4.9%-16.9%
4.3.2.2. Operating Ratio

Measures how efficient Opko is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 2.05 means that the operating costs are 2.05 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Opko Health Inc:

  • The MRQ is 2.055. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.115. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.055TTM2.115-0.060
TTM2.115YOY1.886+0.229
TTM2.1155Y1.823+0.292
5Y1.82310Y1.773+0.050
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0551.311+0.744
TTM2.1151.297+0.818
YOY1.8861.242+0.644
5Y1.8231.224+0.599
10Y1.7731.191+0.582
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Opko Health Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Opko is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 1.63 means the company has 1.63 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Opko Health Inc:

  • The MRQ is 1.630. The company is able to pay all its short-term debts. +1
  • The TTM is 1.718. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.630TTM1.718-0.088
TTM1.718YOY1.785-0.066
TTM1.7185Y1.698+0.021
5Y1.69810Y1.564+0.134
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6302.028-0.398
TTM1.7182.161-0.443
YOY1.7852.484-0.699
5Y1.6982.701-1.003
10Y1.5643.246-1.682
4.4.3.2. Quick Ratio

Measures if Opko is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Opko to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.48 means the company can pay off 0.48 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Opko Health Inc:

  • The MRQ is 0.480. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.557. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.480TTM0.557-0.077
TTM0.557YOY0.667-0.110
TTM0.5575Y0.701-0.144
5Y0.70110Y0.696+0.006
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4801.195-0.715
TTM0.5571.248-0.691
YOY0.6671.684-1.017
5Y0.7012.100-1.399
10Y0.6962.429-1.733
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Opko Health Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Opko assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Opko to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.30 means that Opko assets are financed with 29.5% credit (debt) and the remaining percentage (100% - 29.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Opko Health Inc:

  • The MRQ is 0.295. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.317. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.295TTM0.317-0.022
TTM0.317YOY0.280+0.037
TTM0.3175Y0.300+0.017
5Y0.30010Y0.290+0.011
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2950.433-0.138
TTM0.3170.440-0.123
YOY0.2800.359-0.079
5Y0.3000.425-0.125
10Y0.2900.450-0.160
4.5.4.2. Debt to Equity Ratio

Measures if Opko is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Opko to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 41.9% means that company has 0.42 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Opko Health Inc:

  • The MRQ is 0.419. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.467. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.419TTM0.467-0.048
TTM0.467YOY0.389+0.077
TTM0.4675Y0.431+0.036
5Y0.43110Y0.410+0.021
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4190.640-0.221
TTM0.4670.686-0.219
YOY0.3890.515-0.126
5Y0.4310.666-0.235
10Y0.4100.712-0.302
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Opko generates.

  • Above 15 is considered overpriced but always compare Opko to the Diagnostics & Research industry mean.
  • A PE ratio of -21.29 means the investor is paying -21.29 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Opko Health Inc:

  • The EOD is -28.527. Based on the earnings, the company is expensive. -2
  • The MRQ is -21.290. Based on the earnings, the company is expensive. -2
  • The TTM is -7.924. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-28.527MRQ-21.290-7.237
MRQ-21.290TTM-7.924-13.366
TTM-7.924YOY-9.324+1.399
TTM-7.9245Y-2.138-5.786
5Y-2.13810Y-16.122+13.983
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-28.527-0.344-28.183
MRQ-21.290-0.699-20.591
TTM-7.924-0.881-7.043
YOY-9.324-0.060-9.264
5Y-2.1382.710-4.848
10Y-16.1223.725-19.847
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Opko Health Inc:

  • The EOD is -8.736. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.520. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.917. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.736MRQ-6.520-2.216
MRQ-6.520TTM-1.917-4.603
TTM-1.917YOY-19.663+17.746
TTM-1.9175Y-7.305+5.389
5Y-7.30510Y-4.713-2.592
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-8.736-0.686-8.050
MRQ-6.520-1.466-5.054
TTM-1.917-1.081-0.836
YOY-19.663-1.818-17.845
5Y-7.305-2.252-5.053
10Y-4.713-2.747-1.966
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Opko is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 234.83 means the investor is paying 234.83 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Opko Health Inc:

  • The EOD is 314.649. Based on the equity, the company is expensive. -2
  • The MRQ is 234.825. Based on the equity, the company is expensive. -2
  • The TTM is 275.418. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD314.649MRQ234.825+79.824
MRQ234.825TTM275.418-40.592
TTM275.418YOY275.363+0.055
TTM275.4185Y373.640-98.223
5Y373.64010Y478.103-104.463
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD314.6492.245+312.404
MRQ234.8252.185+232.640
TTM275.4182.311+273.107
YOY275.3632.296+273.067
5Y373.6403.753+369.887
10Y478.1034.561+473.542
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Total Other Income Expense Net -7,930,5404,035,648-3,894,8923,563,348-331,544-1,474,772-1,806,31623,787,88621,981,570



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in ILA. All numbers in thousands.

Summary
Total Assets1,979,871
Total Liabilities584,554
Total Stockholder Equity1,395,317
 As reported
Total Liabilities 584,554
Total Stockholder Equity+ 1,395,317
Total Assets = 1,979,871

Assets

Total Assets1,979,871
Total Current Assets357,981
Long-term Assets1,621,890
Total Current Assets
Cash And Cash Equivalents 40,576
Net Receivables 105,313
Inventory 60,153
Other Current Assets 6,734
Total Current Assets  (as reported)357,981
Total Current Assets  (calculated)212,776
+/- 145,205
Long-term Assets
Property Plant Equipment 128,388
Goodwill 530,106
Long Term Investments 101,485
Intangible Assets 854,111
Long-term Assets Other 7,796
Long-term Assets  (as reported)1,621,890
Long-term Assets  (calculated)1,621,886
+/- 4

Liabilities & Shareholders' Equity

Total Current Liabilities219,553
Long-term Liabilities365,001
Total Stockholder Equity1,395,317
Total Current Liabilities
Short Long Term Debt 22,299
Accounts payable 82,242
Other Current Liabilities 8,872
Total Current Liabilities  (as reported)219,553
Total Current Liabilities  (calculated)113,413
+/- 106,140
Long-term Liabilities
Long term Debt 179,618
Capital Lease Obligations Min Short Term Debt67,532
Long-term Liabilities Other 12,135
Long-term Liabilities  (as reported)365,001
Long-term Liabilities  (calculated)259,285
+/- 105,716
Total Stockholder Equity
Total Stockholder Equity (as reported)1,395,317
Total Stockholder Equity (calculated)0
+/- 1,395,317
Other
Capital Stock7,273
Common Stock Shares Outstanding 696,992
Net Debt 161,341
Net Invested Capital 1,597,234
Net Working Capital 138,428
Property Plant and Equipment Gross 128,388



6.3. Balance Sheets Structured

Currency in ILA. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
2,766,619
2,760,068
2,768,694
2,721,990
2,584,556
2,578,894
2,530,950
2,480,994
2,451,072
2,575,301
2,456,228
2,369,518
2,309,272
2,232,542
2,323,734
2,371,291
2,473,063
2,519,575
2,421,650
2,417,638
2,399,700
2,306,858
2,369,602
2,224,785
2,167,300
2,169,670
2,158,899
2,056,680
2,011,698
1,974,016
1,979,871
1,979,8711,974,0162,011,6982,056,6802,158,8992,169,6702,167,3002,224,7852,369,6022,306,8582,399,7002,417,6382,421,6502,519,5752,473,0632,371,2912,323,7342,232,5422,309,2722,369,5182,456,2282,575,3012,451,0722,480,9942,530,9502,578,8942,584,5562,721,9902,768,6942,760,0682,766,619
   > Total Current Assets 
483,601
459,932
472,516
430,556
343,461
349,346
321,562
289,817
317,731
435,237
344,228
292,842
324,045
274,457
360,054
428,109
523,179
599,049
547,029
557,510
823,013
754,069
494,752
413,971
394,500
406,418
433,789
357,239
309,476
391,303
357,981
357,981391,303309,476357,239433,789406,418394,500413,971494,752754,069823,013557,510547,029599,049523,179428,109360,054274,457324,045292,842344,228435,237317,731289,817321,562349,346343,461430,556472,516459,932483,601
       Cash And Cash Equivalents 
168,733
131,052
130,530
100,362
91,499
99,943
80,381
43,718
96,473
207,250
111,115
64,667
85,452
34,530
21,612
36,294
72,211
89,503
65,757
148,599
134,700
102,281
210,458
180,838
153,200
110,830
108,108
138,621
95,881
75,639
40,576
40,57675,63995,881138,621108,108110,830153,200180,838210,458102,281134,700148,59965,75789,50372,21136,29421,61234,53085,45264,667111,115207,25096,47343,71880,38199,94391,499100,362130,530131,052168,733
       Net Receivables 
220,284
238,893
279,679
263,815
187,052
183,981
176,127
181,647
161,983
144,383
148,287
140,765
157,687
146,699
227,148
256,330
302,256
330,293
275,639
265,527
265,588
221,295
175,140
138,248
127,312
121,486
228,093
117,449
123,379
111,367
105,313
105,313111,367123,379117,449228,093121,486127,312138,248175,140221,295265,588265,527275,639330,293302,256256,330227,148146,699157,687140,765148,287144,383161,983181,647176,127183,981187,052263,815279,679238,893220,284
       Inventory 
47,228
47,492
48,293
46,954
49,333
49,815
46,753
43,379
42,299
44,610
48,293
50,109
61,581
58,697
72,965
111,873
139,600
172,732
134,722
112,861
97,143
99,406
83,306
71,429
74,060
75,411
73,749
68,960
65,697
59,366
60,153
60,15359,36665,69768,96073,74975,41174,06071,42983,30699,40697,143112,861134,722172,732139,600111,87372,96558,69761,58150,10948,29344,61042,29943,37946,75349,81549,33346,95448,29347,49247,228
       Other Current Assets 
47,356
42,495
8,565
12,269
8,207
9,058
10,278
12,135
9,693
4,511
3,234
3,327
15,839
15,786
19,056
7,542
451,000
29,980
33,067
40,858
314,994
316,353
284,300
233,200
241,300
6,081
7,211
7,003
7,673
6,626
6,734
6,7346,6267,6737,0037,2116,081241,300233,200284,300316,353314,99440,85833,06729,980451,0007,54219,05615,78615,8393,3273,2344,5119,69312,13510,2789,0588,20712,2698,56542,49547,356
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
2,140,064
2,112,000
2,076,676
1,985,227
1,958,085
1,963,680
1,943,182
1,949,884
1,920,526
1,874,621
1,860,128
1,576,700
1,552,789
1,874,850
1,810,814
1,772,800
1,763,252
1,725,110
1,699,440
1,702,222
1,582,713
1,621,890
1,621,8901,582,7131,702,2221,699,4401,725,1101,763,2521,772,8001,810,8141,874,8501,552,7891,576,7001,860,1281,874,6211,920,5261,949,8841,943,1821,963,6801,958,0851,985,2272,076,6762,112,0002,140,064000000000
       Property Plant Equipment 
122,831
126,256
133,355
142,437
146,557
148,718
150,156
147,386
144,674
173,242
166,746
164,345
166,491
167,097
169,009
170,587
178,289
177,700
143,001
141,002
123,955
124,667
121,013
119,739
121,604
117,685
113,814
122,860
143,517
127,496
128,388
128,388127,496143,517122,860113,814117,685121,604119,739121,013124,667123,955141,002143,001177,700178,289170,587169,009167,097166,491164,345166,746173,242144,674147,386150,156148,718146,557142,437133,355126,256122,831
       Goodwill 
704,603
705,990
712,075
715,573
717,099
719,891
714,234
713,629
700,193
698,522
699,842
695,798
671,940
669,582
671,599
675,795
680,602
676,162
677,360
674,574
520,601
519,052
578,845
573,499
595,851
597,380
597,375
594,457
598,260
530,615
530,106
530,106530,615598,260594,457597,375597,380595,851573,499578,845519,052520,601674,574677,360676,162680,602675,795671,599669,582671,940695,798699,842698,522700,193713,629714,234719,891717,099715,573712,075705,990704,603
       Long Term Investments 
41,139
37,285
30,958
30,176
37,309
36,285
43,698
41,226
30,373
32,297
24,767
11,695
20,746
10,669
26,260
14,325
15,731
10,314
8,877
11,707
10,713
9,457
108,674
77,783
28,052
41,205
27,745
19,375
16,080
40,987
101,485
101,48540,98716,08019,37527,74541,20528,05277,783108,6749,45710,71311,7078,87710,31415,73114,32526,26010,66920,74611,69524,76732,29730,37341,22643,69836,28537,30930,17630,95837,28541,139
       Intangible Assets 
763,976
746,654
1,377,091
1,362,929
1,331,182
1,314,023
1,294,255
1,277,773
1,250,024
1,232,877
1,216,875
1,199,310
1,119,162
1,103,711
1,089,325
1,076,618
1,065,202
1,046,509
1,035,715
1,024,055
1,110,800
890,498
1,057,409
1,030,136
790,900
998,616
977,195
953,414
935,283
875,034
854,111
854,111875,034935,283953,414977,195998,616790,9001,030,1361,057,409890,4981,110,8001,024,0551,035,7151,046,5091,065,2021,076,6181,089,3251,103,7111,119,1621,199,3101,216,8751,232,8771,250,0241,277,7731,294,2551,314,0231,331,1821,362,9291,377,091746,654763,976
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
3,126
3,770
5,528
6,888
7,026
7,487
5,857
10,060
9,745
9,600
8,744
465,900
9,100
8,898
9,636
981,900
8,340
8,943
9,333
9,080
8,578
7,796
7,7968,5789,0809,3338,9438,340981,9009,6368,8989,100465,9008,7449,6009,74510,0605,8577,4877,0266,8885,5283,7703,126000000000
> Total Liabilities 
674,811
653,098
661,865
632,954
699,178
755,630
720,454
692,351
659,781
812,564
747,297
727,589
694,513
683,923
735,391
747,521
801,512
823,061
679,065
652,071
714,600
691,974
650,803
595,717
605,700
617,860
623,551
612,112
622,479
721,208
584,554
584,554721,208622,479612,112623,551617,860605,700595,717650,803691,974714,600652,071679,065823,061801,512747,521735,391683,923694,513727,589747,297812,564659,781692,351720,454755,630699,178632,954661,865653,098674,811
   > Total Current Liabilities 
263,296
264,951
283,052
258,948
301,335
318,077
306,861
317,830
288,321
396,058
283,374
270,138
249,119
245,087
279,543
335,889
375,483
403,930
303,980
283,035
330,008
309,170
215,472
267,272
213,500
222,422
226,450
200,554
200,052
204,338
219,553
219,553204,338200,052200,554226,450222,422213,500267,272215,472309,170330,008283,035303,980403,930375,483335,889279,543245,087249,119270,138283,374396,058288,321317,830306,861318,077301,335258,948283,052264,951263,296
       Short-term Debt 
11,981
11,527
132,466
16,112
11,926
36,715
36,808
37,310
37,413
112,316
11,240
7,187
9,619
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000009,6197,18711,240112,31637,41337,31036,80836,71511,92616,112132,46611,52711,981
       Short Long Term Debt 
11,981
11,527
132,466
16,112
11,926
36,715
36,808
37,310
37,413
112,316
11,240
7,187
9,619
12,802
14,463
12,702
24,703
17,816
17,961
14,893
14,695
17,412
18,989
93,974
3,100
24,371
28,729
30,118
27,293
22,990
22,299
22,29922,99027,29330,11828,72924,3713,10093,97418,98917,41214,69514,89317,96117,81624,70312,70214,46312,8029,6197,18711,240112,31637,41337,31036,80836,71511,92616,112132,46611,52711,981
       Accounts payable 
251,315
253,424
62,153
66,536
74,307
64,229
69,061
65,613
47,395
51,085
60,376
77,296
62,537
55,866
44,671
65,685
100,883
162,690
88,512
94,393
82,040
94,240
56,107
49,748
67,000
80,503
87,877
66,801
69,677
71,157
82,242
82,24271,15769,67766,80187,87780,50367,00049,74856,10794,24082,04094,39388,512162,690100,88365,68544,67155,86662,53777,29660,37651,08547,39565,61369,06164,22974,30766,53662,153253,424251,315
       Other Current Liabilities 
0
77,556
85,914
59,004
62,548
69,224
67,492
68,346
69,111
67,663
55,775
33,326
60,206
50,477
106,618
123,910
104,585
83,540
65,759
53,685
97,166
79,008
32,342
15,449
45,100
35,900
5,283
41,400
0
9,677
8,872
8,8729,677041,4005,28335,90045,10015,44932,34279,00897,16653,68565,75983,540104,585123,910106,61850,47760,20633,32655,77567,66369,11168,34667,49269,22462,54859,00485,91477,5560
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
416,506
463,923
457,451
445,394
438,836
455,848
411,632
426,029
419,131
375,085
369,036
412,800
382,804
435,331
328,445
392,200
395,438
397,101
411,558
422,427
516,870
365,001
365,001516,870422,427411,558397,101395,438392,200328,445435,331382,804412,800369,036375,085419,131426,029411,632455,848438,836445,394457,451463,923416,506000000000
       Capital Lease Obligations Min Short Term Debt
-11,981
-11,527
-132,466
-16,112
-11,926
-36,715
-36,808
-37,310
-37,413
-70,514
26,490
36,360
36,873
46,236
44,452
42,186
44,046
47,492
45,350
42,190
49,902
49,602
50,211
47,470
49,489
48,810
46,231
56,527
77,237
69,443
67,532
67,53269,44377,23756,52746,23148,81049,48947,47050,21149,60249,90242,19045,35047,49244,04642,18644,45246,23636,87336,36026,490-70,514-37,413-37,310-36,808-36,715-11,926-16,112-132,466-11,527-11,981
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
61,154
49,824
49,642
32,532
29,563
31,833
35,532
29,835
20,323
17,785
16,660
48,200
9,616
9,777
9,096
55,400
11,149
11,020
9,909
12,199
12,166
12,135
12,13512,16612,1999,90911,02011,14955,4009,0969,7779,61648,20016,66017,78520,32329,83535,53231,83329,56332,53249,64249,82461,154000000000
       Deferred Long Term Liability 
165,331
159,286
142,212
118,799
148,729
148,732
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000148,732148,729118,799142,212159,286165,331
> Total Stockholder Equity
2,091,808
2,106,970
2,106,829
2,089,036
1,885,378
1,823,264
1,810,496
1,788,643
1,791,291
1,762,737
1,708,931
1,641,929
1,614,759
1,548,619
1,588,343
1,623,770
1,671,551
1,696,514
1,742,585
1,765,567
1,685,100
1,614,884
1,718,799
1,629,068
1,561,600
1,551,810
1,535,348
1,444,568
1,389,219
1,252,808
1,395,317
1,395,3171,252,8081,389,2191,444,5681,535,3481,551,8101,561,6001,629,0681,718,7991,614,8841,685,1001,765,5671,742,5851,696,5141,671,5511,623,7701,588,3431,548,6191,614,7591,641,9291,708,9311,762,7371,791,2911,788,6431,810,4961,823,2641,885,3782,089,0362,106,8292,106,9702,091,808
   Common Stock
5,586
5,596
5,600
5,600
5,600
5,600
5,602
5,604
5,869
6,162
6,162
6,162
6,704
6,704
6,704
6,706
6,706
6,707
6,898
6,900
6,901
6,902
7,806
7,814
1,561,600
0
7,817
0
0
0
0
00007,81701,561,6007,8147,8066,9026,9016,9006,8986,7076,7066,7066,7046,7046,7046,1626,1626,1625,8695,6045,6025,6005,6005,6005,6005,5965,586
   Retained Earnings Total Equity0000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000
   Other Stockholders Equity 0000-36,94200-58,026-49,171-31,415-30,495-19,923-9,932-13,295-4,225-17,451-25,752-30,187-22,070-28,774-20,351-23,229-20,131-13,138-13,004-539-528-5,422-14,070-24,953-27,009



6.4. Balance Sheets

Currency in ILA. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in ILA. All numbers in thousands.

Gross Profit (+$)
totalRevenue863,495
Cost of Revenue-545,368
Gross Profit318,127318,127
 
Operating Income (+$)
Gross Profit318,127
Operating Expense-1,021,552
Operating Income-158,057-703,425
 
Operating Expense (+$)
Research Development89,593
Selling General Administrative300,559
Selling And Marketing Expenses-
Operating Expense1,021,552390,152
 
Net Interest Income (+$)
Interest Income3,983
Interest Expense-13,506
Other Finance Cost-0
Net Interest Income-9,523
 
Pretax Income (+$)
Operating Income-158,057
Net Interest Income-9,523
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-184,319-141,318
EBIT - interestExpense = -13,506
-188,863
-175,357
Interest Expense13,506
Earnings Before Interest and Taxes (EBIT)--170,813
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-184,319
Tax Provision-4,437
Net Income From Continuing Ops-188,863-188,756
Net Income-188,863
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-16,7399,523
 

Technical Analysis of Opko
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Opko. The general trend of Opko is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Opko's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Opko Health Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 639.20 < 641.00 < 724.30.

The bearish price targets are: 597.20 > 531.00 > 527.80.

Tweet this
Opko Health Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Opko Health Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Opko Health Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Opko Health Inc. The current macd is 14.06.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Opko price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Opko. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Opko price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Opko Health Inc Daily Moving Average Convergence/Divergence (MACD) ChartOpko Health Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Opko Health Inc. The current adx is 16.88.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Opko shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Opko Health Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Opko Health Inc. The current sar is 544.99.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Opko Health Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Opko Health Inc. The current rsi is 60.85. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Opko Health Inc Daily Relative Strength Index (RSI) ChartOpko Health Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Opko Health Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Opko price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Opko Health Inc Daily Stochastic Oscillator ChartOpko Health Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Opko Health Inc. The current cci is 153.55.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Opko Health Inc Daily Commodity Channel Index (CCI) ChartOpko Health Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Opko Health Inc. The current cmo is 27.12.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Opko Health Inc Daily Chande Momentum Oscillator (CMO) ChartOpko Health Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Opko Health Inc. The current willr is -9.09926471.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Opko Health Inc Daily Williams %R ChartOpko Health Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Opko Health Inc.

Opko Health Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Opko Health Inc. The current atr is 27.04.

Opko Health Inc Daily Average True Range (ATR) ChartOpko Health Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Opko Health Inc. The current obv is 38,175,064.

Opko Health Inc Daily On-Balance Volume (OBV) ChartOpko Health Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Opko Health Inc. The current mfi is 27.33.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Opko Health Inc Daily Money Flow Index (MFI) ChartOpko Health Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Opko Health Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Opko Health Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Opko Health Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.848
Ma 20Greater thanMa 50571.715
Ma 50Greater thanMa 100574.578
Ma 100Greater thanMa 200550.623
OpenGreater thanClose624.000
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Opko with someone you think should read this too:
  • Are you bullish or bearish on Opko? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Opko? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Opko Health Inc

I send you an email if I find something interesting about Opko Health Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Opko Health Inc.

Receive notifications about Opko Health Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.